CAFC
20-1871
Sanofi Aventis Deutschland v. Mylan Pharmaceuticals Inc
General
Filed06/10/20
Appeal FromPTAB
Originating CaseIPR2018-01670
Decision12/29/21
Appeal OutcomeAppellee
PACER20-1871
Judges
Judge | Cases | PO Affirm Rate | Ch Affirm Rate |
|---|---|---|---|
| Timothy B. Dyk | 1000+ | 77% | 43% |
| Raymond C. Clevenger, III | 400+ | 73% | 35% |
| Richard G. Taranto | 1000+ | 74% | 25% |
Appellant
Attorney
Name | Ratings |
|---|---|
L5 C | |
L3 B | |
-- -- -- | |
-- -- -- | |
L4 B | |
L3 B | |
L1 D | |
-- -- -- | |
-- -- -- | |
-- -- -- |
No Attorneys
Appellee
Party
Name | Ratings |
|---|---|
-- -- -- | |
United States Patent Trademark Office | -- -- -- |
No Parties
Attorney
Name | Ratings |
|---|---|
L4 A | |
-- -- -- | |
-- -- -- | |
-- -- -- | |
-- -- -- | |
-- -- -- | |
L3 B | |
-- -- -- | |
-- -- -- | |
L3 D | |
L4 A | |
L2 E | |
-- -- -- | |
-- -- -- | |
-- -- -- |
No Attorneys